# OnCo record paper-anbl0532-tandem-transplant-park-jama-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-anbl0532-tandem-transplant-park-jama-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-anbl0532-tandem-transplant-park-jama-2019" ;
  schema:name "ANBL0532: tandem versus single autologous stem cell transplant for high-risk neuroblastoma"@en ;
  schema:description "Two consecutive high-dose chemotherapy courses with stem cell rescue improved three-year event-free survival compared with a single transplant in high-risk neuroblastoma, and the gain was largest in children who went on to receive anti-GD2 immunotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-anbl0532-tandem-transplant-park-jama-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2019.11642>, <https://pubmed.ncbi.nlm.nih.gov/31454045/> ;
  schema:sameAs <https://doi.org/10.1001/jama.2019.11642> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Park JR, Kreissman SG, London WB, et al." ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma-high-risk/> ;
  onco:trials <https://onco.cc/trials/anbl0532/> ;
  onco:journals <https://onco.cc/journals/jama/> .